Showing 1 to 10 of 22 clinical trials
1 | 2 | 3 |
1 |
2 |
3 |
1 | 2 | 3 |
|
CLINICAL TRIALS Trial No ClinicalTrials.gov ID |
Phase | Coordinator | |
|---|---|---|---|
|
Radical External Beam Chemoradiation in Patients With Rectal Cancer: a "Wait-and-see" Approach
14-407 GEN NCT03001362  Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL SITE GLEN |
Phase II |
Tatiana Carvalho 514-934-1934 poste 43698 |
|
A Phase 1/2 Study to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers
MK-9999-02A NCT06428409 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL SITE GLEN |
Rodrigo Skowronski 514-934-1934 poste 36275 |
|
|
Phase II Study to Assess the Safety of Non-operative Management for Low Rectal Cancer
PJT - 148730 (NOM - rectal cancer) NCT03179540 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL HOPITAL SAINT-FRANCOIS D'ASSISE |
Nicole Chabot 418-525-4444 poste 53266 |
|
|
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
CRC10 (NRG-GI008) NCT05174169 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL HOPITAL DE L'ENFANT-JESUS |
Alice Ndayizigiye 418-525-4444 poste 15782 |
|
|
Phase I Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Dosimetry, and Preliminary Activity of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
CFXX489A12101 NCT06562192 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL |
Adeline Hamon 514-890-8000 poste 30737 |
|
|
A Phase 1/2 Study to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers
MK-9999-02A NCT06428409 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL |
Adeline Hamon 514-890-8000 poste 30737 |
|
|
A Pilot Study of Two Dose Escalation Strategies to Increase the Population of Complete Responders After Radiation Therapy in Rectal Cancer Patients.
Morpheus study (no surgery) NCT03051464 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL |
Nassima Taleb 514-890-8000 poste 10812 |
|
|
Advanced Endo-therapeutic Procedure : Registry-based Observational Study
AE Registry NCT04117100 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL |
Samira Hanin 514-890-8000 poste 30916 |
|
|
A Randomized, Open-label Phase 3 Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
OrigAMI-2 NCT06662786 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL |
Chantal Gosselin 514-890-8000 poste 24892 |
|
|
A Phase 2 Nonrandomized, Open-label, Multisite Study to Evaluate the Safety and Efficacy of Raludotatug Deruxtecan in Participants With Gastrointestinal Cancers
MK-5909-005 (REJOICE-GI01) NCT06864169 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL |
Adeline Hamon 514-890-8000 poste 30737 |
Groupe d'étude en oncologie du Québec